NTP Study Reports
Abstract for TR-249 - Amosite Asbestos
TR-249
Lifetime Carcinogenesis Studies of Amosite Asbestos
(CAS No. 12172-73-5) in Syrian Golden Hamsters (Feed Studies)
Structural Formula: (FeC2+Mg)6· Si8O22(OH)2
Carcinogenesis studies of amosite asbestos were conducted by administering diets containing 1% of the asbestos in pellets from the conception of the mothers through the lifetime of male and female Syrian golden hamsters. Control groups consisted of 127 male and 126 female hamsters and the amosite asbestos groups consisted of 252 male and 254 female hamsters.
No adverse effect on body weight gain or survival was observed from treatment with amosite asbestos. Neither of the amosite asbestos groups showed increased neoplasia in any organ or tissue compared to the control groups.
Under the conditions of these studies, the ingestion of amosite asbestos at a level of 1% in the diet for their lifetime was not toxic and did not cause a carcinogenic response in male and female Syrian golden hamsters.
Levels of Evidence of Carcinogenicity: | ||
Male Hamsters: | Negative | |
Female Hamsters: | Negative |
Note: Amosite Asbestos was subsequently tested in F344 rats administered in feed (See TR-279, reported 1990).
Report Date: November 1983
Target Organs & Incidences from 2-year Studies
You may link to the full technical report in pdf format ( Note: A print ready copy of the document is presented in Portable Document Format (pdf) which requires the Acrobat Reader plug-in -- download a free copy of the reader.)
Web page last updated on October 14, 2004